![Brendan O’Leary](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Brendan O’Leary currently works at Xalud Therapeutics, Inc., as Chief Operating Officer from 2021.
Brendan O’Leary active positions
| Companies | Position | Start |
|---|---|---|
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company advancing a non-viral plasmid DNA delivered gene therapy platform to treat pathologic inflammation | Chief Operating Officer | 2021-05-10 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company advancing a non-viral plasmid DNA delivered gene therapy platform to treat pathologic inflammation | Health Technology |
- Stock Market
- Insiders
- Brendan O’Leary
